Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
68 | 4500 | 30.0 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
850 | 11038 | ESOPHAGEAL CANCER//ESOPHAGECTOMY//ESOPHAGEAL CARCINOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ESOPHAGEAL CANCER | Author keyword | 303 | 26% | 22% | 1004 |
2 | ESOPHAGEAL CARCINOMA | Author keyword | 79 | 26% | 6% | 257 |
3 | OESOPHAGEAL CANCER | Author keyword | 62 | 28% | 4% | 190 |
4 | ESOPHAGECTOMY | Author keyword | 54 | 22% | 5% | 218 |
5 | DEFINITIVE CHEMORADIOTHERAPY | Author keyword | 35 | 81% | 0% | 21 |
6 | CHEMORADIOTHERAPY | Author keyword | 32 | 13% | 5% | 228 |
7 | SALVAGE ESOPHAGECTOMY | Author keyword | 30 | 100% | 0% | 12 |
8 | DISEASES OF THE ESOPHAGUS | Journal | 27 | 13% | 4% | 196 |
9 | ESOPHAGEAL NEOPLASMS | Author keyword | 19 | 21% | 2% | 82 |
10 | NEOADJUVANT THERAPY | Author keyword | 15 | 12% | 3% | 117 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ESOPHAGEAL CANCER | 303 | 26% | 22% | 1004 | Search ESOPHAGEAL+CANCER | Search ESOPHAGEAL+CANCER |
2 | ESOPHAGEAL CARCINOMA | 79 | 26% | 6% | 257 | Search ESOPHAGEAL+CARCINOMA | Search ESOPHAGEAL+CARCINOMA |
3 | OESOPHAGEAL CANCER | 62 | 28% | 4% | 190 | Search OESOPHAGEAL+CANCER | Search OESOPHAGEAL+CANCER |
4 | ESOPHAGECTOMY | 54 | 22% | 5% | 218 | Search ESOPHAGECTOMY | Search ESOPHAGECTOMY |
5 | DEFINITIVE CHEMORADIOTHERAPY | 35 | 81% | 0% | 21 | Search DEFINITIVE+CHEMORADIOTHERAPY | Search DEFINITIVE+CHEMORADIOTHERAPY |
6 | CHEMORADIOTHERAPY | 32 | 13% | 5% | 228 | Search CHEMORADIOTHERAPY | Search CHEMORADIOTHERAPY |
7 | SALVAGE ESOPHAGECTOMY | 30 | 100% | 0% | 12 | Search SALVAGE+ESOPHAGECTOMY | Search SALVAGE+ESOPHAGECTOMY |
8 | ESOPHAGEAL NEOPLASMS | 19 | 21% | 2% | 82 | Search ESOPHAGEAL+NEOPLASMS | Search ESOPHAGEAL+NEOPLASMS |
9 | NEOADJUVANT THERAPY | 15 | 12% | 3% | 117 | Search NEOADJUVANT+THERAPY | Search NEOADJUVANT+THERAPY |
10 | SUPERFICIAL ESOPHAGEAL CANCER | 15 | 56% | 0% | 18 | Search SUPERFICIAL+ESOPHAGEAL+CANCER | Search SUPERFICIAL+ESOPHAGEAL+CANCER |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THORACIC ESOPHAGUS | 505 | 68% | 10% | 439 |
2 | 3 FIELD LYMPHADENECTOMY | 167 | 78% | 2% | 109 |
3 | GASTROESOPHAGEAL JUNCTION | 143 | 36% | 7% | 317 |
4 | ESOPHAGOGASTRIC JUNCTION | 133 | 29% | 9% | 384 |
5 | EN BLOC ESOPHAGECTOMY | 132 | 83% | 2% | 74 |
6 | DEFINITIVE CHEMORADIOTHERAPY | 130 | 64% | 3% | 129 |
7 | TRANSHIATAL ESOPHAGECTOMY | 105 | 40% | 5% | 208 |
8 | NEOADJUVANT CHEMORADIOTHERAPY | 94 | 42% | 4% | 171 |
9 | EXTENDED RADICAL ESOPHAGECTOMY | 89 | 90% | 1% | 38 |
10 | LIMITED TRANSHIATAL RESECTION | 88 | 65% | 2% | 84 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DISEASES OF THE ESOPHAGUS | 27 | 13% | 4% | 196 |
2 | ESOPHAGUS | 12 | 22% | 1% | 49 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Medical progress - Esophageal cancer | 2003 | 1174 | 103 | 36% |
Multimodality Approaches for the Curative Treatment of Esophageal Cancer | 2015 | 1 | 62 | 92% |
Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers | 2014 | 11 | 54 | 74% |
Value of Functional Imaging by PET in Esophageal Cancer | 2015 | 1 | 77 | 86% |
Worldwide esophageal cancer collaboration | 2009 | 130 | 8 | 63% |
Current management of esophageal cancer | 2014 | 13 | 71 | 52% |
A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer | 2003 | 348 | 33 | 82% |
SURGICAL THERAPY OF ESOPHAGEAL-CARCINOMA | 1990 | 671 | 92 | 86% |
Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities | 2007 | 138 | 52 | 96% |
The history of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery | 2015 | 1 | 23 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ESOPHAGEAL SURG | 11 | 35% | 0.6% | 26 |
2 | SE WALES CANC NETWORK | 11 | 78% | 0.2% | 7 |
3 | GEN VISCERAL CANC SURG | 8 | 26% | 0.6% | 27 |
4 | SURG ESOPHAGEAL SURG | 6 | 47% | 0.2% | 9 |
5 | INTERNAL MED HAEMATOL MED ONCOL 3 | 6 | 100% | 0.1% | 4 |
6 | SERV CHIRURG DIGEST GEN | 5 | 19% | 0.5% | 22 |
7 | FRONTIER SURG | 4 | 16% | 0.6% | 25 |
8 | GUANGDONG ESOPHAGEAL CANC | 4 | 75% | 0.1% | 3 |
9 | MERIDIAN CANC CARE | 4 | 75% | 0.1% | 3 |
10 | RADIOL ABDOMINAL INTERVENT RADIOL | 4 | 75% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000211328 | ESOPHAGECTOMY//MINIMALLY INVASIVE ESOPHAGECTOMY//ESOPHAGOGASTRIC ANASTOMOSIS |
2 | 0.0000115037 | ESOPHAGUS GRAFTS AND PROSTHESES//MALIGNANT DYSPHAGIA//ESOPHAGORESPIRATORY FISTULA |
3 | 0.0000108372 | CANCER PATTERN//ESOPHAGEAL CANCER SURVIVAL//GASTRIC INVASION |
4 | 0.0000100410 | STOMACH NEOPLASMS//STOMACH CT//VIRTUAL GASTROSCOPY |
5 | 0.0000061080 | NARROW BAND IMAGING//GASTRIC TUBE CANCER//INTRAEPITHELIAL PAPILLARY CAPILLARY LOOP |
6 | 0.0000054412 | BARRETTS ESOPHAGUS//BARRETTS OESOPHAGUS//ESOPHAGEAL ADENOCARCINOMA |
7 | 0.0000052642 | EARLY GASTRIC CANCER//GASTRECTOMY//D2 LYMPHADENECTOMY |
8 | 0.0000048273 | HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2//ADVANCED METASTATIC DISEASE//ANTI EGF RECEPTOR ANTIBODY |
9 | 0.0000044938 | PHARYNGOESOPHAGEAL RECONSTRUCTION//FREE JEJUNAL GRAFT//LARYNGOPHARYNGECTOMY |
10 | 0.0000044575 | HIGH INCIDENCE AREA//HEBEI TUMOR HOSP//GOLESTAN GASTROENTEROL HEPATOL |